AI Just Compressed 160 Years of Aging Research — Here's What They Found | Dr. David Sinclair

Aging functions as an information degradation problem where cells lose their original, youthful state due to epigenetic noise. By leveraging AI to simulate protein structures and screen billions of potential molecules, researchers can now identify treatments that bypass traditional, slow-moving drug development timelines. This approach relies on the hypothesis that cells contain a "backup copy" of youthful information, which can be accessed to reset biological age. Recent breakthroughs in mouse and monkey models have demonstrated the ability to reverse age-related damage, including regrowing optic nerves and restoring function in tissues previously considered permanently degraded. Dr. David Sinclair, a leading researcher in this field, emphasizes that while the complexity of cellular biology remains immense, AI-driven insights are transforming our ability to manipulate these fundamental processes, potentially enabling the treatment of age-related diseases like Alzheimer's and even systemic rejuvenation.